Global health workers are making inroads in the fight to diagnose and treat tuberculosis (TB) but there are still major gaps in treating patients suffering from its multidrug-resistant form, the World Health Organization (WHO) reports.
Health system weaknesses and a lack of effective regimens are blamed for unacceptably low cure rates, but the agency says the multidrug resistant TB (MDR-TB) response is also “seriously hampered by insufficient funding”.
The WHO report, published on October 22 2014, reveals that in 2013, an estimated 9 million people developed TB, including MDR-TB, and 1.5 million died from the disease, 360,000 of which were HIV-positive. The proportion of new cases with MDR-TB was 3.5%.
- Disorders & Diseases
- Public Health
- Products & Treatment
- Department Management
- Edition Archive